In one paragraphArticle in Mediators of inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
22 authors.
Dominique RevetsDepartment of Translational Medicine Operations Hub (TMOH), Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Andreas MichalsenEpidemiology and Health Economics, Institute of Social Medicine, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-9145-7246 Etienne HanslianEpidemiology and Health Economics, Institute of Social Medicine, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-8683-5011 Daniela A KoppoldEpidemiology and Health Economics, Institute of Social Medicine, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-3367-3327 Nico SteckhanEpidemiology and Health Economics, Institute of Social Medicine, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-0245-2046 Michael JeitlerEpidemiology and Health Economics, Institute of Social Medicine, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-3277-9090 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Arthritis, RheumatoidB-LymphocytesImmunoglobulin DImmunophenotypingMemory B CellsTumor Necrosis Factor Receptor Superfamily, Member 7AdultAgedFemaleFlow CytometryHumansMaleMiddle AgedImmunoglobulin DTumor Necrosis Factor Receptor Superfamily, Member 7autoimmunityCyTOFIgD+CD27+ unswitched memory b cellsimmunologyimmunophenotypingrheumatoid arthritis
Identifiers
PMID40766288
PMCPMC12324914
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390